The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Bioactive iridium and rhodium complexes as therapeutic agents
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
Signalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793
Tumor necrosis factor signaling
Wajant, H., Pfizenmaier, K., & Scheurich, P. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401189 · Cited by 2,359
Protein kinases — the major drug targets of the twenty-first century?
Cohen, P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd773 · Cited by 2,186
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Soucy, T. A., Smith, P. G., Milhollen, M. A., Berger, A. J., Gavin, J. M., Adhikari, S., Brownell, J. E., Burke, K. E., Cardin, D. P., Critchley, S., et al. (2009) · Nature · doi:10.1038/nature07884 · Cited by 1,990
The atomic structure of protein-protein recognition sites 1 1Edited by A. R. Fersht
Conte, L. L., Chothia, C., & Janin, J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2439 · Cited by 1,964
The JAK/STAT signaling pathway
Rawlings, J. S., Rosler, K. M., & Harrison, D. A. (2004) · Journal of Cell Science · doi:10.1242/jcs.00963 · Cited by 1,858
The status of platinum anticancer drugs in the clinic and in clinical trials
Wheate, N. J., Walker, S., Craig, G. E., & Oun, R. (2010) · Dalton Transactions · doi:10.1039/c0dt00292e · Cited by 1,634
Organometallic Anticancer Compounds
Gasser, G., Ott, I., & Metzler-Nolte, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100020w · Cited by 1,624
A Road Map for Those Who Don't Know JAK-STAT
Aaronson, D. S., & Horvath, C. M. (2002) · Science · doi:10.1126/science.1071545 · Cited by 1,337
Bioorganometallic chemistry—from teaching paradigms to medicinal applications
Hartinger, C. G., & Dyson, P. J. (2009) · Chem. Soc. Rev. · doi:10.1039/b707077m · Cited by 985
Structure-based maximal affinity model predicts small-molecule druggability
Cheng, A. C., Coleman, R. G., Smyth, K. T., Cao, Q., Soulard, P., Caffrey, D. R., Salzberg, A. C., & Huang, E. S. (2007) · Nature Biotechnology · doi:10.1038/nbt1273 · Cited by 695
Platinum(IV) antitumour compounds: their bioinorganic chemistry
Hall, M. D., & Hambley, T. W. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00026-7 · Cited by 622
Small-Molecule Inhibition of TNF-α
He, M. M., Smith, A. S., Oslob, J. D., Flanagan, W. M., Braisted, A. C., Whitty, A., Cancilla, M. T., Wang, J., Lugovskoy, A. A., Yoburn, J. C., et al. (2005) · Science · doi:10.1126/science.1116304 · Cited by 620
van Rijt, S. H., & Sadler, P. J. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.09.003 · Cited by 592
Aird, R. E., Cummings, J., Ritchie, A. A., Muir, M., Morris, R. E., Chen, H., Sadler, P. J., & Jodrell, D. I. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600290 · Cited by 582
Ruthenium Complexes as Anticancer Agents
Kostova, I. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776360941 · Cited by 566
Inhibition of transcription by platinum antitumor compounds
Todd, R. C., & Lippard, S. J. (2009) · Metallomics · doi:10.1039/b907567d · Cited by 539
Targeting proteins with metal complexes
Meggers, E. (2009) · Chemical Communications · doi:10.1039/b813568a · Cited by 450
Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs
Bergamo, A., & Sava, G. (2011) · Dalton Transactions · doi:10.1039/c0dt01816c · Cited by 440
Nedd8 on cullin: building an expressway to protein destruction
Pan, Z.-Q., Kentsis, A., Dias, D. C., Yamoah, K., & Wu, K. (2004) · Oncogene · doi:10.1038/sj.onc.1207414 · Cited by 429
Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis
Karkkainen, M. J., & Petrova, T. V. (2000) · Oncogene · doi:10.1038/sj.onc.1203855 · Cited by 427
Bioactive Luminescent Transition‐Metal Complexes for Biomedical Applications
Ma, D., He, H., Leung, K., Chan, D. S., & Leung, C. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201208414 · Cited by 388
Self-citationDesigning organometallic compounds for catalysis and therapy
Noffke, A. L., Habtemariam, A., Pizarro, A. M., & Sadler, P. J. (2012) · Chemical Communications · doi:10.1039/c2cc30678f · Cited by 370
Organometallic Half-Sandwich Iridium Anticancer Complexes
Liu, Z., Habtemariam, A., Pizarro, A. M., Fletcher, S. A., Kisova, A., Vrana, O., Salassa, L., Bruijnincx, P. C. A., Clarkson, G. J., Brabec, V., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2000932 · Cited by 357
A categorization of metal anticancer compounds based on their mode of action
Gianferrara, T., Bratsos, I., & Alessio, E. (2009) · Dalton Transactions · doi:10.1039/b905798f · Cited by 336
Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
Boulikas, T. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903114168 · Cited by 276
Identification of the Activating and Conjugating Enzymes of the NEDD8 Conjugation Pathway
Gong, L., & Yeh, E. T. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.12036 · Cited by 270
Structurally Sophisticated Octahedral Metal Complexes as Highly Selective Protein Kinase Inhibitors
Feng, L., Geisselbrecht, Y., Blanck, S., Wilbuer, A., Atilla-Gokcumen, G. E., Filippakopoulos, P., Kräling, K., Celik, M. A., Harms, K., Maksimoska, J., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja1112996 · Cited by 239
Metal-based antitumour drugs in the post-genomic era: what comes next?
Sava, G., Bergamo, A., & Dyson, P. J. (2011) · Dalton Transactions · doi:10.1039/c1dt10522a · Cited by 231
Iridium(iii) complexes as therapeutic and bioimaging reagents for cellular applications
Lo, K. K.-W., & Zhang, K. Y. (2012) · RSC Advances · doi:10.1039/c2ra20967e · Cited by 227
Metal complexes in medicine with a focus on enzyme inhibition
Che, C.-M., & Siu, F.-M. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.11.015 · Cited by 224
Cobalt derivatives as promising therapeutic agents
Heffern, M. C., Yamamoto, N., Holbrook, R. J., Eckermann, A. L., & Meade, T. J. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2012.11.019 · Cited by 204
Rhodium(III) and iridium(III) complexes as anticancer agents
Geldmacher, Y., Oleszak, M., & Sheldrick, W. S. (2012) · Inorganica Chimica Acta · doi:10.1016/j.ica.2012.06.046 · Cited by 194
Schäfer, S., Ott, I., Gust, R., & Sheldrick, W. S. (2007) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200700206 · Cited by 175
Lau, J. S.-Y., Lee, P.-K., Tsang, K. H.-K., Ng, C. H.-C., Lam, Y.-W., Cheng, S.-H., & Lo, K. K.-W. (2009) · Inorganic Chemistry · doi:10.1021/ic801818x · Cited by 174
Iridium Complex with Antiangiogenic Properties
Wilbuer, A., Vlecken, D. H., Schmitz, D. J., Kräling, K., Harms, K., Bagowski, C. P., & Meggers, E. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000682 · Cited by 168
A Metal‐Based Inhibitor of Tumor Necrosis Factor‐α
Leung, C., Zhong, H., Yang, H., Cheng, Z., Chan, D. S., Ma, V. P., Abagyan, R., Wong, C., & Ma, D. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201202937 · Cited by 164
Self-citationFrom Conventional to Unusual Enzyme Inhibitor Scaffolds: The Quest for Target Specificity
Meggers, E. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201005673 · Cited by 158
Protein kinase Cδ and apoptosis
Reyland, M. E. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351001 · Cited by 148
A Metal‐Based Inhibitor of Tumor Necrosis Factor‐α
Leung, C., Zhong, H., Yang, H., Cheng, Z., Chan, D. S., Ma, V. P., Abagyan, R. A., Wong, C., & Ma, D. (2012) · Angewandte Chemie · doi:10.1002/ange.201202937 · Cited by 142
Self-citationMan, B. Y.-W., Chan, H., Leung, C., Chan, D. S., Bai, L., Jiang, Z., Li, H., & Ma, D. (2011) · Chemical Science · doi:10.1039/c0sc00636j · Cited by 136
Self-citationProtein surface recognition and proteomimetics: mimics of protein surface structure and function
Fletcher, S., & Hamilton, A. D. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.10.006 · Cited by 135
Barry, N. P. E., & Sadler, P. J. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15300a · Cited by 129
Structure‐Based Discovery of Natural‐Product‐like TNF‐α Inhibitors
Chan, D. S., Lee, H., Yang, F., Che, C., Wong, C. C. L., Abagyan, R. A., Leung, C., & Ma, D. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200907360 · Cited by 127
Self-citationMelnikova, I., & Golden, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1600 · Cited by 121
Lo, K. K., Lee, P.-K., & Lau, J. S.-Y. (2008) · Organometallics · doi:10.1021/om800212t · Cited by 116
Kastl, A., Wilbuer, A., Merkel, A. L., Feng, L., Fazio, P. D., Ocker, M., & Meggers, E. (2011) · Chemical Communications · doi:10.1039/c1cc15378a · Cited by 110
Aguirre, J. D., Angeles-Boza, A. M., Chouai, A., Pellois, J., Turró, C., & Dunbar, K. R. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9021717 · Cited by 103
Polypyridyl Metal Complexes with Biological Activity
Salassa, L. (2011) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201100376 · Cited by 95
Ruiz, J., Rodríguez, V., Cutillas, N., Samper, K. G., Capdevila, M., Palacios, Ò., & Ferao, A. E. (2012) · Dalton Transactions · doi:10.1039/c2dt31654d · Cited by 87
A natural product-like inhibitor of NEDD8-activating enzyme
Leung, C., Chan, D. S., Yang, H., Abagyan, R. A., Lee, S. M., Zhu, G., Fong, W. F., & Ma, D. (2011) · Chemical Communications · doi:10.1039/c0cc04927a · Cited by 85
Self-citationJoyce, L. E., Aguirre, J. D., Angeles-Boza, A. M., Chouai, A., Fu, P. K. ‐., Dunbar, K. R., & Turró, C. (2010) · Inorganic Chemistry · doi:10.1021/ic100588d · Cited by 83
Anand, R., Maksimoska, J., Pagano, N., Wong, E., Gimotty, P. A., Diamond, S. L., Meggers, E., & Marmorstein, R. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8005806 · Cited by 78
Kilah, N. L., & Meggers, E. (2012) · Australian Journal of Chemistry · doi:10.1071/ch12275 · Cited by 69
Zhong, H., Ma, V. P., Cheng, Z., Chan, D. S., He, H., Leung, K., Ma, D., & Leung, C. (2012) · Biochimie · doi:10.1016/j.biochi.2012.06.004 · Cited by 63
Self-citationAguirre, J. D., Angeles-Boza, A. M., Chouai, A., Turró, C., Pellois, J., & Dunbar, K. R. (2009) · Dalton Transactions · doi:10.1039/b915357h · Cited by 62
Geldmacher, Y., Splith, K., Kitanović, I., et al. (2012) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-012-0883-2 · Cited by 59
DNA‐Binding Small Molecules as Inhibitors of Transcription Factors
Leung, C., Chan, D. S., Ma, V. P., & Ma, D. (2013) · Medicinal Research Reviews · doi:10.1002/med.21266 · Cited by 58
Self-citationSelective Cytotoxicity of Rhodium Metalloinsertors in Mismatch Repair-Deficient Cells
Ernst, R. J., Komor, A. C., & Barton, J. K. (2011) · Biochemistry · doi:10.1021/bi2015822 · Cited by 58
Nazif, M. A., Rubbiani, R., Alborzinia, H., Kitanović, I., Wölfl, S., Ott, I., & Sheldrick, W. S. (2012) · Dalton Transactions · doi:10.1039/c2dt00011c · Cited by 44
The ubiquitin proteasome system and its involvement in cell death pathways
Bernassola, F., Ciechanover, A. J., & Melino, G. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.189 · Cited by 43
Structure‐Based Repurposing of FDA‐Approved Drugs as TNF‐α Inhibitors
Leung, C., Chan, D. S., Kwan, M. H., Cheng, Z., Wong, C., Zhu, G., Fong, W. F., & Ma, D. (2011) · ChemMedChem · doi:10.1002/cmdc.201100016 · Cited by 42
Self-citationOrganometallic Pyridylnaphthalimide Complexes as Protein Kinase Inhibitors
Blanck, S., Cruchter, T., Vultur, A., Riedel, R., Harms, K., Herlyn, M., & Meggers, E. (2011) · Organometallics · doi:10.1021/om200366r · Cited by 41
Geldmacher, Y., Kitanović, I., Alborzinia, H., Bergerhoff, K. F., Rubbiani, R., Wefelmeier, P., Prokop, A., Gust, R., Ott, I., Wölfl, S., et al. (2011) · ChemMedChem · doi:10.1002/cmdc.201000517 · Cited by 40
Targeting the proteasome pathway
Tsukamoto, S., & Yokosawa, H. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902866851 · Cited by 39
Organometallics as Structural Scaffolds for Enzyme Inhibitor Design
Mulcahy, S. P., & Meggers, E. (2010) · Topics in organometallic chemistry · doi:10.1007/978-3-642-13185-1_6 · Cited by 36
Inhibition of Janus kinase 2 by cyclometalated rhodium complexes
Leung, C., Yang, H., Ma, V. P., Chan, D. S., Zhong, H., Li, Y., Fong, W. F., & Ma, D. (2012) · MedChemComm · doi:10.1039/c2md00306f · Cited by 34
Self-citationAnticancer dirhodium(ii,ii) carboxylates as potent inhibitors of ubiquitin-proteasome system
Siu, F., Lin, I. W., Yan, K., Lok, C., Low, K., Leung, T. Y.-C., Lam, T. L., & Che, C. (2012) · Chemical Science · doi:10.1039/c2sc00620k · Cited by 32
Aguirre, J. D., Chifotides, H. T., Angeles-Boza, A. M., Chouai, A., Turró, C., & Dunbar, K. R. (2009) · Inorganic Chemistry · doi:10.1021/ic900164j · Cited by 32
Lemaire, P., & Livingstone, D. R. (1994) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.2570090206 · Cited by 29
Bioactive cyclometalated phthalimides: design, synthesis and kinase inhibition
Blanck, S., Geisselbrecht, Y., Kräling, K., Middel, S., Mietke, T., Harms, K., Essen, L., & Meggers, E. (2012) · Dalton Transactions · doi:10.1039/c2dt30940h · Cited by 27
Cyclometalated phenylquinoline rhodium complexes as protein kinase inhibitors
Mollin, S., Blanck, S., Harms, K., & Meggers, E. (2012) · Inorganica Chimica Acta · doi:10.1016/j.ica.2012.04.035 · Cited by 25
Yang, X., Gong, Y., & Friesel, R. E. (2012) · PLoS ONE · doi:10.1371/annotation/eb3485a7-612b-4244-8d2a-43a80cdd15eb · Cited by 19
Cited by
Organoiridium Complexes: Anticancer Agents and Catalysts
Liu, Z., & Sadler, P. J. (2014) · Accounts of Chemical Research · doi:10.1021/ar400266c · Cited by 573
Recent development of biotin conjugation in biological imaging, sensing, and target delivery
Ren, W. X., Han, J., Uhm, S., Jang, Y. J., Kang, C., Kim, J.-H., & Kim, J. S. (2015) · Chemical Communications · doi:10.1039/c5cc03075g · Cited by 393
Recent Advances in Subcellular Targeted Cancer Therapy Based on Functional Materials
Chen, W., Luo, G., & Zhang, X. (2019) · Advanced Materials · doi:10.1002/adma.201802725 · Cited by 373
Metal Drugs and the Anticancer Immune Response
Englinger, B., Pirker, C., Heffeter, P., Terenzi, A., Kowol, C. R., Keppler, B. K., & Berger, W. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00396 · Cited by 355
Update on metal N-heterocyclic carbene complexes as potential anti-tumor metallodrugs
Liu, W., & Gust, R. (2016) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2016.09.004 · Cited by 351
Metadata
- Authors
- Leung, C.-H., Zhong, H.-J., Chan, D. S.-H., & Ma, D.-L.
- Venue
- Coordination Chemistry Reviews
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 257
- Issue
- 11-12
- Pages
- 1764-1776
- ISSN
- 0010-8545 (ISSN-L)
- OpenAlex
- W2048981336
- Cited by
- 303
- References
- 74
- FWCI
- 12.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.